Wikipedia

Mitochondrial antiviral-signaling protein

(Redirected from IPS-1)

Mitochondrial antiviral-signaling protein (MAVS) is a protein that is essential for antiviral innate immunity. MAVS is located in the outer membrane of the mitochondria, peroxisomes, and mitochondrial-associated endoplasmic reticulum membrane (MAM).[5][6] Upon viral infection, a group of cytosolic proteins will detect the presence of the virus and bind to MAVS, thereby activating MAVS. The activation of MAVS leads the virally infected cell to secrete cytokines. This induces an immune response which kills the host's virally infected cells, resulting in clearance of the virus.

MAVS
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesMAVS, CARDIF, IPS-1, IPS1, VISA, mitochondrial antiviral signaling protein
External IDsOMIM: 609676; MGI: 2444773; HomoloGene: 17004; GeneCards: MAVS; OMA:MAVS - orthologs
Orthologs
SpeciesHumanMouse
Entrez

57506

228607

Ensembl

ENSG00000088888

ENSMUSG00000037523

UniProt

Q7Z434

Q8VCF0

RefSeq (mRNA)

NM_001206491
NM_020746
NM_001385663

NM_001206382
NM_001206383
NM_001206385
NM_144888

RefSeq (protein)

NP_001193420
NP_065797

NP_001193311
NP_001193312
NP_001193314
NP_659137

Location (UCSC)Chr 20: 3.85 – 3.88 MbChr 2: 131.08 – 131.09 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Structure

edit
 
Schematic representation of MAVS gene. Ribosome recognition sites for translation are located at position 1 and position 142 on the MAVS gene, highlighted by the yellow band.

MAVS is also known as IFN-β promoter stimulator I (IPS-1), caspase activation recruitment domain adaptor inducing IFN-β(CARDIF), or virus induced signaling adaptor (VISA).[7] MAVS is encoded by a MAVS gene.[7][8] MAVS is a 540 amino acid protein that consists of three components, a N terminal caspase activation recruitment domain (CARD), a proline rich domain, and a transmembrane C terminal domain (TM).[7]

After the MAVS gene has been transcribed into RNA, ribosomes can translate the MAVS protein from two different sites.[7] The initial translation site generates the full-length MAVS protein. The alternative translation site generates a shorter protein, termed as “miniMAVS” or short-MAVS (sMAVS).[7] sMAVS is a 398 amino acid MAVS protein that lacks the CARD domain. This is significant because the CARD domain is where two cytosolic proteins bind to activate MAVS, signaling that there is a virus present in the cell.[7]

Function

edit

Double stranded RNA viruses are recognized by either the transmembrane toll-like receptor 3 (TLR3) or by one of two cytosolic proteins, retinoic acid-inducible gene I (RIG-I)-like receptors and melanoma differentiation-associated gene 5 (MDA5).[7][8][9][10] RIG-I and MDA5 differ in the viral RNA that they recognize, but they share many structural features, including the N-terminal CARD that allows them to bind to MAVS.[7] MAVS activation leads to the increased levels of pro-inflammatory cytokines via activation of transcription factors, nuclear factor kB (NF-κB), interferon regulatory factor 1 (IRF1), and interferon regulatory factor 3 (IRF3).[7][8][9] NF-κB, IRF1, and IRF3 are transcription factors and play critical roles in the production of cytokines.

 
Cellular mechanisms of MAVS pathway

At a resting state for the cell, a protein called mitofusin 2 (MFN2) is known to interact with MAVS, preventing MAVS from binding to the cytosolic proteins, such as RIG-I and MDA5.[7][8] Upon recognition of the virus in the cytosol, mitochondria-associated ER membranes (MAM) and mitochondria will become physically tethered by MFN2 and RIG-I binds to a second RIG-I protein to form a protein complex.[7][8][9] This complex binds to TRIM25 and molecular chaperone 14-3-3e to form a complex termed “translocon”.[7][8][9][10] The translocon travels to the mitochondria where it binds to the CARD region on MAVS, leading to activation of MAVS.[7][8][9][10] Subsequently, MAVS proteins bind to each other through the CARD and TM domain to recruit several downstream signaling factors to form the MAVS signaling complex.[7][8] The formation of this MAVS signaling complex is aided by augmented levels of mitochondrial reactive oxygen species (mROS), independent of the RNA sensing.[8][9] The MAVS signaling complex interacts with TANK binding kinase 1 and/or protein kinases IKKA (CHUK) and IKKB (IKBKB), which leads to the phosphorylation and nuclear translocation of IRF3.[7] Although MAVS signal transduction and regulation is not fully understood, activated MAVS proteins in the mitochondria, ER, and peroxisome are needed to maximize the antiviral innate immune response.

MAVS protein induces apoptosis in host virally infected cells by interacting with a protease called caspase 8.[7] Activation of apoptosis by caspase 8 is independent of the Bax/Bak apoptotic pathway, the main pathway of apoptosis in cells.[7]

Viral evasion

edit

Certain viruses, such as human cytomegalovirus (HCMV) and hepatitis C (HCV), have adapted to suppress the function of MAVS in the antiviral innate immune response, aiding in viral replication.[7][11] HCMV impairs MAVS through the viral mitochondria-localized inhibitor of apoptosis protein (vMIA), thus reducing the pro-inflammatory cytokine response.[11] vMIA also localizes to the peroxisome where it interacts with cytoplasmic chaperone protein Pex19, disabling the transport machinery of peroxisomal membrane proteins.[11] The HCV NS3-NS4A strain inactivates MAVS signaling by cleaving the MAVS protein directly upstream of MAVS membrane-targeting domain in the MAM and peroxisome, preventing MAVS downstream signaling.[7]

Regulation

edit

The expression and function of MAVS are regulated at the transcriptional, posttranscriptional, and posttranslational level. At the transcriptional level, the reactive oxygen species (ROS) generated during antiviral response acts as a negative regulator.[7][8][9] MAVS, additionally, encodes a number of splice variants that have been proposed to regulate MAVS. At the post-transcriptional level, there are two translational sites present on MAVS that can generate two proteins of MAVS. The alternative translation site resides upstream, resulting in expression of sMAVS.[7][8][9] At the translational level, proteins such as a family of ubiquitin E3 ligase regulate MAVS activity.[7][8][9]

References

edit
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000088888 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000037523 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Vazquez C, Beachboard DC, Horner SM (2017). "Methods to Visualize MAVS Subcellular Localization". Innate Antiviral Immunity. Methods in Molecular Biology. Vol. 1656. pp. 131–142. doi:10.1007/978-1-4939-7237-1_7. ISBN 978-1-4939-7236-4. PMC 6103534. PMID 28808966.
  6. ^ Seth RB, Sun L, Ea CK, Chen ZJ (September 2005). "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3". Cell. 122 (5): 669–682. doi:10.1016/j.cell.2005.08.012. PMID 16125763. S2CID 11104354.
  7. ^ a b c d e f g h i j k l m n o p q r s t u v Vazquez C, Horner SM (July 2015). "MAVS Coordination of Antiviral Innate Immunity". Journal of Virology. 89 (14): 6974–6977. doi:10.1128/JVI.01918-14. PMC 4473567. PMID 25948741.
  8. ^ a b c d e f g h i j k l Mohanty A, Tiwari-Pandey R, Pandey NR (September 2019). "Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response". Journal of Cell Communication and Signaling. 13 (3): 303–318. doi:10.1007/s12079-019-00507-9. PMC 6732146. PMID 30719617.
  9. ^ a b c d e f g h i Jacobs JL, Coyne CB (December 2013). "Mechanisms of MAVS regulation at the mitochondrial membrane". Journal of Molecular Biology. 425 (24): 5009–5019. doi:10.1016/j.jmb.2013.10.007. PMC 4562275. PMID 24120683.
  10. ^ a b c Jiang QX (2019). "Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs". Medicinal Chemistry. 15 (5): 443–458. doi:10.2174/1573406415666181219101613. PMC 6858087. PMID 30569868.
  11. ^ a b c Ashley CL, Abendroth A, McSharry BP, Slobedman B (2019). "Interferon-Independent Innate Responses to Cytomegalovirus". Frontiers in Immunology. 10: 2751. doi:10.3389/fimmu.2019.02751. PMC 6917592. PMID 31921100.

Further reading

edit

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Mitochondrial_antiviral-signaling_protein&oldid=1241177822"